Skip to main content
SpringerLink
Log in

Osteoporosis and Metabolic Bone Disease

  • Chapter
  • First Online:
Bone Pathology

Abstract

The chapter discusses bone metabolism and regulation under normal conditions. It also discusses disease conditions that affect the skeleton as a whole including osteo-porosis, rickets, osteomalacia, scurvy, renal osteodystrophy, hyperparthyroidism, storage disorders and amyloidosis. Paget disease is also discussed here because of tradition and its similarity to other generalized skeletal disorders despite some evidence that it might be due to an infective viral agent. Similaryly, largely because of tradition, osteopetrosis, pycnodysostosis and osteogenesis imperfecta are discussed although they could be discussed amongst genetic disorders (inherited and dysplastic conditions) of the skeleton.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Murray TM, Rao LG, Divieti P, Bringhurst FR. Parathyroid hormone secretion and action: Evidence for discrete receptors for the carboxyl-terminal region and related biological actions of carboxyl-terminal ligands. Endo Rev 26:78–113, 2005.

    Article  CAS  Google Scholar 

  2. Bringhurst FR, Stern AM, Yotts, M, Mizrahi N, Segre GV, Potts JT, Jr. Peripheral metabolism of PTH: Fate of biologically active amino terminus in vivo. Am J Physiol 255:E886–E893, 1988.

    PubMed  CAS  Google Scholar 

  3. Friedman PA, Goodman, WG. PTH(1–84/PTH(7–84): A balance of power. Am J Physiol Renal Physiol 290:F975–F084, 2006.

    Article  PubMed  CAS  Google Scholar 

  4. Liu S, Gupta A, Quarles LD. Emerging role of fibroblast growth factor 23 and in a bone-kidney axis regulating phosphate homeostasis and extracellular matrix mineralization. Curr Opin Nephrol Hypertens 16:329–335, 2007.

    Article  PubMed  CAS  Google Scholar 

  5. Imel EA, Econs MJ. Fibrous dysplasia, phosphate wasting and fibroblast growth factor 23. Pediatr Endocrinol Rev 4:434–439, 2007.

    PubMed  Google Scholar 

  6. Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med 94:646–650, 1993

    Google Scholar 

  7. Raisz L. Pathogenesis of osteoporosis: Concepts, conflicts and prospects. J Clin Invest 115:3318–3325, 2005.

    Article  PubMed  CAS  Google Scholar 

  8. Rosen CJ. Postmenopausal osteoporosis. N Engl J Med 353:595–603, 2005.

    Article  PubMed  CAS  Google Scholar 

  9. WHO Technical Report Series 921 Prevention and management of osteoporosis, 2000.

    Google Scholar 

  10. Giguere Y, Rousseau F. The genetics of osteoporosis: Complexities and difficulties. Clin Genet 57:161–169, 2000.

    Article  PubMed  CAS  Google Scholar 

  11. Morrison NA, Qi JC, Tokita A, Kelly PJ, Crofts L, Nguyen TV, Sambrook PN, Eisman JA. Prediction of bone density from vitamin D receptor alleles. Nature 367:284–216, 1994.

    Article  PubMed  CAS  Google Scholar 

  12. Uitterlinden AG, et al. Relation of alleles of the collagen type I-alpha-1 gene to bone density and the risk of osteoporotic fractures in postmenopausal women. N Engl J Med 338:1016–1021, 1998.

    Article  PubMed  CAS  Google Scholar 

  13. Mankin HJ. Rickets, osteomalacia and renal osteodystrophy Part I. J Bone Joint Surg 56-A (1):101–128, 1974.

    Google Scholar 

  14. Holick MF. High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc 81:353–373, 2006.

    Article  PubMed  CAS  Google Scholar 

  15. Bielesz B. Emerging role of a phosphatonin in mineral homeostasis and its derangements. Eur J Clin Invest 36 (Suppl 2):34–42, 2006.

    Article  PubMed  CAS  Google Scholar 

  16. Hochberg Z. Vitamin-D-dependent rickets type 2. Hormone Res 58:297–302, 2002.

    Article  PubMed  CAS  Google Scholar 

  17. Collins MT. Spectrum and national history of fibrous dysplasia of bone. J Bone Miner Res 21 (Suppl 2):P99–P104, 2006.

    Article  PubMed  Google Scholar 

  18. Riminucci M, Gehron Robey P, Biano P. The pathology of fibrous dysplasia and the McCune-Albright syndrome. Pediatr Endocrinol Rev 4:401–411, 2007.

    PubMed  Google Scholar 

  19. Fitzpatrick LA. Pathophysiology of bone loss in patients receiving anticonvulsant therapy. Epilepsy Behav 5:S3–S15, 2004.

    Article  PubMed  Google Scholar 

  20. Chavassieux P, Seeman E, Delmas PD. Insights into material and structural basis of bone fragility from diseases associated with fractures: How determinants of the biochemical properties of bone are compromised by disease. Endo Rev 28:151–164, 2007.

    Article  CAS  Google Scholar 

  21. Gal-Moscovici A, Sprague SM. Bone health in chronic kidney disease-mineral and bone disease. Adv Chronic Kidney Dis 14(1):27–36, 2007.

    Article  PubMed  Google Scholar 

  22. Hruska KA, Saab G, Mathew S, Lund R. Renal osteodystrophy, phosphate homeostasis, and vascular calcification. Semin Dial 20(4):309–15, 2007.

    Article  PubMed  Google Scholar 

  23. Silverberg SJ, Bilezikian JP. The diagnosis and management of asymptomatic primary hyperparathyroidism. Nat Clin Pract Endo­crinol Metab 2:494–503, 2005.

    Article  Google Scholar 

  24. Lowe H, McMahon DJ, Rubin MR, Bilezikian JP, Silverberg SJ. Normocalcemic primary hyperparathyroidism: Further characterization of a new clinical phenotype. J Clin Endocrinol Metab 92:3001–3005, 2007.

    Article  PubMed  CAS  Google Scholar 

  25. Layfield R, Shaw B. Ubiquitin-mediated signaling and Paget’s disease of bone. BMC Biochem 8 (Suppl 1):1–7, 2007.

    Article  Google Scholar 

  26. Siris ES, Roodman GD. Paget’s Disease of Bone. In: Primer on the Metabolic Bone Disease and Disorders of Mineral Metabolism. 6th edition. Edited by M.J. Favus. American Society for Bone and Mineral Research, Washington, D.C. pp. 320–330, 2006.

    Google Scholar 

  27. Picken MM. New insights into systemic amyloidosis: The importance of diagnosis of specific type. Curr. Opin. Nephrol. Hypertens. 16:196–203, 2007.

    Google Scholar 

  28. Comenzo RL. Current and emerging views and treatment of systemic light-chain (AL) amyloidosis. Contrib Nephrol 153:195–210, 2007.

    Article  PubMed  CAS  Google Scholar 

  29. Whyte MP, Chines A, Silva DP, Landt Y, Ladenson JH. Creatine kinase brain isoenzyme (BB-CK) presence in serum distinguishes osteopetrosis among the sclerosing bone disorders. J Bone Miner Res 11:1438–1443, 1996.

    Article  PubMed  CAS  Google Scholar 

  30. Tolar J, Teitelbaum SL, Orchard PJ. Osteopetrosis. N Engl J Med 351:2839–2849, 2004.

    Article  PubMed  Google Scholar 

  31. Brockstedt H, Bollerslev J, Melsen F, Mosekilde L. Cortical bone remodeling in autosomal dominant osteopetrosis: A study of two different phenotypes. Bone 18:67–72, 1996.

    Article  PubMed  CAS  Google Scholar 

  32. Marini J. Osteoporosis Imperfecta. In: Primer on the Metabolic Bone Disease and Disorders of Mineral Metabolism. 6th edition edited by M.J. Favus. American Society for Bone and Mineral Research, Washington, D.C. pp. 418–421, 2006.

    Google Scholar 

  33. Jaffe HL. Osteogenesis Imperfecta. In: Metabolic, Degenerative and Inflammatory Diseases of Bones and Joints. Lea Febige, Philadelphia, 1972.

    Google Scholar 

  34. Muenzer J. The mucopolysaccharidoses: A heterogeneous group of disorders with variable pediatric presentations. J Pediatr 144:S27–S34, 2004.

    Article  PubMed  CAS  Google Scholar 

  35. Vellodi A. Lysosomal storage disorders. Br J Haematol 128:413–431, 2004.

    Article  Google Scholar 

  36. Rimoin DL, Silberberg R, Hollister DW. Chondro-osseous pathology in the chondrodystrophies. Clin Orthop 114:137–152, 1976.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, Temple Univesity School of Medicine, Philadelphia, PA, 19140, USA

    Jasvir S. Khurana

  2. Musculoskeletal Diseases and Women’s Health Clinical Development, GlaxoSmithKline RN 420 2301 Renaissance Blvd King of Prussia, Prussia, PA, 19406, USA

    Lorraine A. Fitzpatrick (Group Director)

Authors
  1. Jasvir S. Khurana
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lorraine A. Fitzpatrick
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jasvir S. Khurana .

Editor information

Editors and Affiliations

  1. Dept. Pathology, Temple University Hospital, N. Broad St. 3401, Philadelphia, 19140, U.S.A.

    Jasvir S. Khurana

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Humana Press, a part of Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Khurana, J.S., Fitzpatrick, L.A. (2009). Osteoporosis and Metabolic Bone Disease. In: Khurana, J. (eds) Bone Pathology. Humana Press. https://doi.org/10.1007/978-1-59745-347-9_14

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-347-9_14

  • Published:

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-766-2

  • Online ISBN: 978-1-59745-347-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation